UN puts AI Titans on the hook for billions of dollars of biopiracy payments
By Jim Thomas,
Scan the Horizon
| 11. 19. 2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. The decision, while seemingly about paying for genetic data, sets a significant wider precedent for how AI firms can be held accountable for stealing training data without consent or recompense.
Here is the context: After years of stand-offs and diplomatic wrangling, the United Nation’s Convention on Biological Diversity (UN CBD) this month adopted a landmark decision on something called “DSI”. DSI stands for Digital Sequence Information. It refers to digital versions of biological ‘codes’ such as DNA, RNA or the amino acids in proteins. These biological “codes” are routinely collected, stored and processed in digital form and have become the raw commodity powering the global$1.5 trillion dollar biotech industry. Originally sequenced from plants, animals, bacteria and viruses extracted from territories (plus human medical samples) the sheer volume of ‘DSI’ now stacking up in servers and databases rivals much of...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...